 REDWOOD CITY, Calif., Aug. 31, 2022 GLOBE NEWSWIRE -- Bolt Biotherapeutics Nasdaq: BOLT, a clinical-stage biopharmaceutical company developing novel immuno-oncology therapeutics for the treatment of cancer, today announced that management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022, at 12:20 p.m. ET 9:20 a.m. PT in New York, New York. 